Alberico L Catapano Selected Research

Prediabetic State (Prediabetes)

1/2022	Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: A post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials.
1/2018	Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract.
12/2016	Effect on Fasting Serum Glucose Levels of Adding Ezetimibe to Statins in Patients With Nondiabetic Hypercholesterolemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alberico L Catapano Research Topics

Disease

83	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 06/2003
36	Atherosclerosis 03/2024 - 06/2003
29	Hypercholesterolemia 05/2024 - 10/2004
23	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 05/2024 - 03/2015
15	Myocardial Infarction 05/2024 - 05/2002
14	Coronary Disease (Coronary Heart Disease) 01/2024 - 12/2003
12	Dyslipidemias (Dyslipidemia) 12/2020 - 02/2010
9	Homozygous Familial Hypercholesterolemia 05/2024 - 08/2014
8	Inflammation (Inflammations) 03/2024 - 12/2010
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2023 - 04/2008
8	Stroke (Strokes) 08/2022 - 04/2005
6	Inborn Genetic Diseases (Disease, Hereditary) 05/2024 - 02/2018
6	Acute Coronary Syndrome 10/2023 - 11/2012
6	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2007
4	Ischemic Stroke 05/2024 - 11/2014
4	Peripheral Arterial Disease 05/2024 - 01/2018
4	Aortic Valve Stenosis (Aortic Stenosis) 05/2024 - 12/2021
4	COVID-19 01/2023 - 01/2022
4	Atherosclerotic Plaque (Atheroma) 12/2022 - 07/2003
4	Pancreatitis 10/2021 - 08/2014
4	Vascular Diseases (Vascular Disease) 01/2021 - 12/2009
4	Neoplasms (Cancer) 01/2020 - 04/2013
4	Insulin Resistance 01/2020 - 10/2007
4	Diabetes Mellitus 01/2018 - 05/2015
3	Infections 01/2023 - 10/2016
3	Coronary Artery Disease (Coronary Atherosclerosis) 12/2022 - 09/2015
3	Prediabetic State (Prediabetes) 01/2022 - 12/2016
3	Heart Failure 01/2022 - 02/2010
3	Gout 10/2020 - 01/2019
3	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 04/2017 - 05/2015
3	Muscular Diseases (Myopathy) 01/2017 - 06/2011
3	Hypertension (High Blood Pressure) 06/2016 - 10/2007
2	Chronic Disease (Chronic Diseases) 01/2023 - 05/2022
2	Dementia (Dementias) 01/2022 - 10/2013
2	Hemorrhage 12/2021 - 11/2021
2	Overweight 05/2021 - 12/2015
2	Chronic Renal Insufficiency 12/2020 - 07/2020
2	Death (Near-Death Experience) 10/2020 - 12/2013
2	Myalgia 09/2020 - 05/2015
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 02/2010
2	Hypotension (Low Blood Pressure) 01/2020 - 10/2007
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020 - 01/2018
2	Cataract (Cataracts) 01/2019 - 01/2018
2	Hypertriglyceridemia 10/2015 - 08/2013
2	Xanthomatosis (Xanthoma) 08/2014 - 12/2013

Drug/Important Bio-Agent (IBA)

54	oxidized low density lipoproteinIBA 05/2024 - 05/2002
49	LDL CholesterolIBA 05/2024 - 12/2003
47	LipidsIBA 05/2024 - 06/2003
44	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2024 - 05/2002
25	CholesterolIBA 05/2024 - 05/2002
16	Lipoproteins (Lipoprotein)IBA 05/2024 - 10/2007
14	HDL CholesterolIBA 10/2021 - 08/2007
12	Ezetimibe (Zetia)FDA Link 01/2022 - 10/2006
11	8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA 01/2024 - 01/2019
10	Triglycerides (Triacylglycerol)IBA 12/2021 - 10/2007
9	Lipoprotein(a)IBA 10/2023 - 03/2015
8	LDL Lipoproteins (beta Lipoproteins)IBA 12/2022 - 03/2006
7	C-Reactive ProteinIBA 02/2024 - 12/2008
7	ApolipoproteinsIBA 01/2022 - 10/2007
7	Apolipoproteins B (ApoB)IBA 01/2022 - 10/2007
6	Glucose (Dextrose)FDA LinkGeneric 04/2023 - 10/2007
6	HDL LipoproteinsIBA 01/2023 - 07/2003
6	Simvastatin (Zocor)FDA LinkGeneric 06/2016 - 10/2006
5	Proprotein Convertase 9IBA 01/2023 - 12/2016
5	Monoclonal AntibodiesIBA 01/2022 - 01/2019
5	Rosuvastatin Calcium (Crestor)FDA Link 01/2022 - 10/2006
4	Proteins (Proteins, Gene)FDA Link 03/2024 - 10/2018
4	EnzymesIBA 10/2020 - 03/2006
4	Fibric Acids (Fibrates)IBA 01/2019 - 06/2011
4	Atorvastatin (Lipitor)FDA Link 10/2013 - 04/2008
3	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2017
3	omega-Chloroacetophenone (Mace)IBA 01/2024 - 10/2020
3	evinacumabIBA 01/2022 - 12/2020
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2021 - 11/2012
3	LDL Receptors (LDL Receptor)IBA 11/2020 - 02/2012
3	lipoprotein cholesterolIBA 01/2020 - 10/2007
3	mipomersenIBA 01/2019 - 08/2014
3	Pravastatin (Pravachol)FDA LinkGeneric 11/2017 - 03/2013
2	Therapeutic UsesIBA 03/2024 - 05/2010
2	Apolipoprotein C-IIIIBA 12/2023 - 10/2015
2	Peptides (Polypeptides)IBA 01/2023 - 03/2012
2	RivaroxabanIBA 12/2021 - 11/2021
2	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 11/2014
2	Fenofibrate (CiL)FDA LinkGeneric 01/2021 - 04/2016
2	Uric Acid (Urate)IBA 10/2020 - 06/2011
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2020 - 08/2013
2	alirocumabIBA 01/2020 - 01/2017
2	Adenosine Triphosphate (ATP)IBA 01/2020 - 12/2009
2	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2019 - 12/2003
2	Apolipoproteins E (ApoE)IBA 01/2018 - 10/2017
2	IncretinsIBA 01/2017 - 05/2015
2	Niacin (Nicotinic Acid)FDA LinkGeneric 11/2014 - 06/2011
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 12/2008 - 10/2007
2	HomocysteineIBA 11/2007 - 05/2002
2	Folic Acid (Vitamin M)FDA LinkGeneric 11/2007 - 05/2002

Therapy/Procedure

42	Therapeutics 05/2024 - 01/2008
5	Secondary Prevention 01/2021 - 09/2005
2	Blood Component Removal (Apheresis) 05/2024 - 10/2022
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 05/2024 - 12/2003
2	Mediterranean Diet 04/2023 - 05/2022